Project Fast Infant Neurodevelopmental Diagnosis via Outpatient Testing (FIND-OUT): Expanded Pool and Protocol for genome sequencing in symptomatic infants

ASHG 2026

Oct 20, 2026
Neuro/Psych
Presentation

Katie Schmidt, Elizabeth Rountree, Corinne Hunnicutt, Lauren Gale, Deborah Ondrasik, Natasha Ludwig, Jennifer Harmon, Sho Yano, Seth Berger, Terry Jo Bichell

Abstract
Despite guidelines, the time between diagnosis and initial concern is long, averaging 30 months. Often, caregivers notice something amiss long before a diagnosis of global developmental delay or intellectual delay. Project FIND-OUT developed a list of common symptoms for caregivers and non-genetic specialists to identify infants suspected of rare genetic neurodevelopmental disorders (RGNDs) before their first birthday and to provide genome sequencing (GS) at the first sign of concern.

 

Inclusion criteria were developed by a core panel, based on a literature review, and with input from experts and families of children diagnosed with RGNDs. Families could either “self-refer” by completing an initial eligibility form or be referred to the study by a healthcare provider. If infants met ≥2 of the FIND-OUT criteria (e.g., Feeding Issues, Issues with movement, NICU admission, Developmental Delay, Other [specialist referral, growth abnormality, and/or congenital anomaly], Unprovoked Seizures, or Tone issues), were ≤ 12 months of age, and resided in the United States, they were eligible for GS. Results were returned within eight weeks. The study’s initial patients were probands (n=79); for patients with a VUS, parental single-gene testing was performed. After switching to an insurance-based model, families could receive simultaneous trio or duo testing (n=11). Other follow-up testing that would help clarify findings (e.g., episignatures) was provided by the project.

 

Total enrollment from September 2023 - May 2026 was 90 infants. The overall diagnostic yield was 25.8% (n = 23). There were 67 self-referred families; 14 of these received a pathogenic diagnosis (20.9%). Self-referred families found the study through social media (e.g., Facebook, Instagram) and other online channels. There were 23 families referred by their child’s provider; of these, 9 were given pathogenic diagnoses (39.1%). Enrolled infants met an average of 4 criteria, with “Other” being the most prevalent category. Of the 89 results returned, 23 (25.8%) were positive, 15 (16.9%) were VUS, and 37 (41.6%) were negative.

 

These accessible criteria show promise for early identification of infants at risk for RGNDs, leading to appropriate interventions that profoundly impact the care an individual receives.